| Long noncoding RNA insulin growth factor 2 antisense is acting as an epigenetic tumor suppressor in human prostate cancer, likely through inverse regulation on IGF2#This is the parental gene. | None |
| IGF2 is critical for tumorigenesis by synovial sarcoma oncoprotein SYT-SSX1. | sarcoma, |
| The region of the genome containing the imprinted genes insulin-like growth factor 2 (Igf2) and H19, both of which display oncogenic functions, may be particularly sensitive to environmental influences | None |
| Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis. | None |
| Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activation. | None |
| IGF-II isoforms possess unique biological properties that may enable them to escape normal sequestration avenues and remain bioavailable in vivo to sustain oncogenic signaling | None |
| IGF2 expression in infantile hemangioma is strongly related to the expression of a cancer testes and suspected oncogene BORIS. | None |
| IGF2 was identified here as a key factor in anal squamous cell carcinoma (ASCC) oncogenesis, as IGF2 was shown to play a crucial role in the PI3K pathway. IGF2 expression is mainly due to cancer-associated fibroblasts and that IGF2 secreted by cancer-associated fibroblasts from ASCC samples promotes proliferation of a human ASCC cell line via IGF2 paracrine signaling. | None |